- Home
- lulu bravo
- PH needs vaccine for dengue as disease remains a threat despite drop in cases – expert
PH needs vaccine for dengue as disease remains a threat despite drop in cases – expert
4.6 (619) · $ 19.99 · In stock
Dengue fever cases dramatically decreased during the COVID-19 pandemic, but the tropical disease remains a threat to the Philippines, especially during the rainy season, with outbreaks always a possibility. “We need a vaccine for dengue,” Dr. Lulu Bravo, a vaccine expert, told INQUIRER.net in an online interview on Wednesday, the last day of June, which was National Dengue Awareness Month.
Nipah virus disease: what can we do to improve patient care? - The
Breast Cancer Awareness Month
Excluding ranking, figures, and indexes, why does Vietnam feel
Vaccine case study: Exploring the controversy around Dengvaxia and
DOH reports drop in dengue cases nationwide from Jan 1 to Feb 10
South America dengue spike prompts vaccination drive as bug spray runs out
The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study
A multiple-target mRNA-LNP vaccine induces protective immunity
Vaccine case study: Exploring the controversy around Dengvaxia and
Vaccination for kids
Dengvaxia controversy haunts Duterte's COVID vaccine roll out
Dengue: Practice Essentials, Background, Pathophysiology
Philippines Orders Probe into Suspended Dengue Vaccine
Epidemiologic Trends of Dengue in U.S. Territories, 2010–2020
(PDF) Refined efficacy estimates of the Sanofi Pasteur dengue
